Dr. Hilary Bagshaw

Claim this profile

Stanford Cancer Institute Palo Alto

Studies Prostate Cancer
Studies Adenocarcinoma
2 reported clinical trials
14 drugs studied

Affiliated Hospitals

Image of trial facility.
Stanford Cancer Institute Palo Alto
Image of trial facility.
Stanford Cancer Center South Bay

Clinical Trials Hilary Bagshaw is currently running

Image of trial facility.

Hormone + Radiation Therapy

for Prostate Cancer

This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria

More about Hilary Bagshaw

Clinical Trial Related6 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Hilary Bagshaw has experience with
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Stereotactic Body Radiation Therapy (SBRT)
  • Abiraterone Acetate
  • Apalutamide
  • Bicalutamide
  • Buserelin
Breakdown of trials Hilary Bagshaw has run
Prostate Cancer
Adenocarcinoma
Prostate Adenocarcinoma
Tumors
Bone Metastasis

Other Doctors you might be interested in

Melinda Telli, MDGSK Investigational Site
Andrei Iagaru, MDStanford University, School of Medicine
George A. FisherStanford University

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hilary Bagshaw specialize in?
Hilary Bagshaw focuses on Prostate Cancer and Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved treating patients, or patients who are undergoing treatment.
Is Hilary Bagshaw currently recruiting for clinical trials?
Yes, Hilary Bagshaw is currently recruiting for 1 clinical trial in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Hilary Bagshaw has studied deeply?
Yes, Hilary Bagshaw has studied treatments such as Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), Abiraterone Acetate.
What is the best way to schedule an appointment with Hilary Bagshaw?
Apply for one of the trials that Hilary Bagshaw is conducting.
What is the office address of Hilary Bagshaw?
The office of Hilary Bagshaw is located at: Stanford Cancer Institute Palo Alto, Palo Alto, California 94304 United States. This is the address for their practice at the Stanford Cancer Institute Palo Alto.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top